Zealand Pharma A/S — Quarterly Results & Earnings

₹59.50

+0.00%

Profit Growth YoY-49.73%Latest quarter

Sales Growth YoY0.56%Latest quarter

Sales CAGR 5Y36.90%5 year compound

Profit CAGR 5Y62.94%5 year compound

📋

Quarterly Performance

YoY Profit Growth-49.73%

🔴 Significant decline

YoY Sales Growth+0.56%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

7.56%

EPS Growth 5Y

-12.34%

Interest Coverage

Higher = safer debt servicing

8.56

ROE

19.60%

ROCE

23.80%

💡

Growth Analysis

Zealand Pharma A/S reported YoY profit growth of -49.73% and revenue growth of 0.56% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 36.90% and profits at 62.94% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Zealand Pharma A/S

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Logistics Solution Provider Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.